1. Home
  2. CXDO vs ELUT Comparison

CXDO vs ELUT Comparison

Compare CXDO & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CXDO

Crexendo Inc.

HOLD

Current Price

$5.79

Market Cap

189.9M

ML Signal

HOLD

Logo Elutia Inc.

ELUT

Elutia Inc.

HOLD

Current Price

$0.85

Market Cap

42.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CXDO
ELUT
Founded
1995
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medical Specialities
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
189.9M
42.5M
IPO Year
1999
2020

Fundamental Metrics

Financial Performance
Metric
CXDO
ELUT
Price
$5.79
$0.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
1
Target Price
$9.20
$6.00
AVG Volume (30 Days)
263.7K
49.2K
Earning Date
05-05-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
166.67
146.77
EPS
0.05
N/A
Revenue
$68,167,000.00
$12,293,000.00
Revenue This Year
$45.26
N/A
Revenue Next Year
$13.31
$10.83
P/E Ratio
$116.20
N/A
Revenue Growth
12.05
N/A
52 Week Low
$5.54
$0.50
52 Week High
$11.23
$1.39

Technical Indicators

Market Signals
Indicator
CXDO
ELUT
Relative Strength Index (RSI) N/A 42.58
Support Level N/A $0.80
Resistance Level N/A $1.01
Average True Range (ATR) 0.00 0.07
MACD 0.00 0.00
Stochastic Oscillator 0.00 22.35

Price Performance

Historical Comparison
CXDO
ELUT

About CXDO Crexendo Inc.

Crexendo Inc is a software technology company that provides cloud communication platform software and unified communications as a service (UCaaS) offering, including voice, video, contact center, and managed IT services. The company operates through two segments: Cloud Telecommunications Services and Software Solutions. Its cloud telecommunications segment generates revenue from the provision of broadband Internet services, managed IT services, software license sales, and infrastructure as a service. The software solutions segment derives revenues from three primary sources: software licenses, software maintenance support and professional services. The majority of the company's revenue is derived from the Cloud Telecommunications Services segment.

About ELUT Elutia Inc.

Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.

Share on Social Networks: